Introduction the first published description of using a recombinant virus to deliver vaccine antigens from another infectious agent was the vaccinia virus recombinant engineered to express hepatitis b surface antigen in animal cells which upon immunization in chimpanzees induced protective immune response against hepatitis b challenge since then numerous breakthroughs have been made in . Viral vectors represent an attractive way to deliver and present vaccine antigens that may offer advantages over traditional platforms among the most attractive and efficient viral vectors in inducing a cellular immune response vaccinia virus has been the most used in leishmaniases vaccine trials. The development of vaccines against viral diseases such as smallpox genital herpes and avian influenza is a high public health priority however in each case there are issues associated with . Cooney el collier ac greenberg pd et al safety of and immunological response to a recombinant vaccinia virus vaccine expressing hiv envelope glycoprotein lancet 1991337567 72 anonymous recombinant vaccinia viruses as live virus vectors for vaccine antigens memorandum from a who usphs nibsc meeting. Get this from a library vaccinia viruses as vectors for vaccine antigens proceedings of the workshop on vaccinia viruses as vectors for vaccine antigens held november 13 14 1984 in chevy chase maryland usa gerald v quinnan
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )